Avantax Advisory Services, Inc. Chembio Diagnostics, Inc. Transaction History

Avantax Advisory Services, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$2.88 - $5.64 $107,804 - $211,116	-37,432 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.4 - $7.97 $55,396 - $129,855	16,293 Added 77.08%	37,432 $131,000
Q4 2020 Jan 22, 2021	BUY	$4.11 - $7.51 $86,881 - $158,753	21,139 New	21,139 $100,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.